Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 2/2005

01-06-2005 | Oral Presentation

Dissection of molecular pathways of cancer by high-throughput biochip technologies and RNA interference

Author: O Kallioniemi

Published in: Breast Cancer Research | Special Issue 2/2005

Login to get access

Excerpt

Our aim is to identify new molecular targets and mechanisms for therapeutic intervention in cancer. To achieve this aim, we develop and apply multiple high-throughput technologies including 'in silico' screening as well as technologies for molecular, cellular and clinical discovery research. Finally, data integration from these technology platforms is applied to facilitate interpretation and prioritization of the findings. …
Metadata
Title
Dissection of molecular pathways of cancer by high-throughput biochip technologies and RNA interference
Author
O Kallioniemi
Publication date
01-06-2005
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 2/2005
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr1086

Other articles of this Special Issue 2/2005

Breast Cancer Research 2/2005 Go to the issue

Poster Presentation

Independent prognostic value of somatic TP53gene mutations in 1794 breast cancer patients

Poster Presentation

Predicting survival from gene expression data by generalized partial least squares regression

Oral Presentation

ATM mutations associated with breast cancer

Oral Presentation

Genomic profiling of breast cancer

Poster Presentation

Myoepithelial cell layer disruption and human breast cancer invasion

Poster Presentation

Hypermethylation of cyclin D2 and DAP kinase is associated with the lobular subtype of breast cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits